JenaValve họpụtara Kari Moore ka ọ bụrụ onye isi na-ahụ maka ego

IRVINE, Calif., Mee 17, 2022 (GLOBE NEWSWIRE) - JenaValve Technology, Inc. ("JenaValve ma ọ bụ ụlọ ọrụ"), onye nrụpụta na onye nrụpụta nke sistemu transcatheter aortic valve nnọchi (TAVR), taa mara ọkwa ọkwa nke Kari Moore dị ka onye isi njikwa ego nke ụlọ ọrụ ahụ dị irè na Mee 10, 2022. "Anyị nwere obi ụtọ ịnabata Kari na ndị otu JenaValve," JenaValve CEO John Kilcoyne kwuru. ụlọ ọrụ nlekọta ahụike. Nnukwu ihe ọmụma nke Kari na nka ụlọ ọrụ ga-enyere anyị aka ịga n'ihu na-eme atụmatụ ụlọ ọgwụ anyị ma kwalite Trilogy anyị maka ọgwụgwọ ọrịa valvụ aortic ® Commercialization Efforts for Heart Valve Systems." Nwada Moore sonyeere JenaValve mgbe o jere ozi dị ka Chief Accounting Officer maka Envista Holdings Corporation, ụlọ ọrụ ngwaahịa eze zuru ụwa ọnụ, ebe ọ na-ahụ maka ọrụ ndekọ ego zuru ụwa ọnụ, ego na òkè ọrụ. Tupu ịbanye Envista Holdings Corporation, Ms. Moore bụ onye isi. Onye na-ahụ maka akaụntụ nke Applied Medical Corporation, ụlọ ọrụ ngwaọrụ ahụike zuru ụwa ọnụ na-enye teknụzụ na ngwọta maka ịwa ahụ pere mpe na izugbe.Ms. Moore malitere ọrụ ya na PricewaterhouseCoopers, ebe ọ rụrụ ọrụ dị ka onye mmekọ nyocha, ọkachamara na ụlọ ọrụ sayensị ndụ. N'ime afọ 20 ọ na-arụ ọrụ, Oriakụ Moore ewerela ọtụtụ ụlọ ọrụ ọha na eze ma nyere ha aka n'ịzụta, divestitures na ụgwọ ụgwọ.Kari na-ejide. BA na nchịkwa azụmahịa sitere na Mahadum Southern California ma bụrụ CPA na steeti California. "Enwere m obi ụtọ isonyere JenaValve n'oge dị oke egwu," Oriakụ Moore kwuru. "Enwere m obi ụtọ iso ndị otu JenaValve niile na-arụkọ ọrụ ka anyị na-aga n'ihu na-eme atụmatụ uto na uru anyị na-emepụta ma na-eme ka ndụ ndị ọrịa dịkwuo mma." Banyere JenaValve JenaValve Technology, Inc., nke dị na Irvine, California, na ebe dị na Leeds, UK na Munich, Germany, na-etolite ma na-emepụta usoro transcatheter aortic valve nnọchi (TAVR) maka ọgwụgwọ nke ndị ọrịa nwere ọrịa aortic valve. JenaValve na-akwado ya. Bain Capital Life Sciences na Cormorant Asset Management, yana ndị na-etinye ego na Europe na Asia gụnyere Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners na Peijia Medical Limited (HKEx: 9996) . United States: Ntị - Akụrụngwa Nchọpụta. Amachibidoro iwu gọọmenti etiti (ma ọ bụ US) maka iji naanị nyocha.